無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の多血小板血漿(PRP)市場(純多血小板血漿(P-PRP)、白血球・多血小板血漿(L-PRP)、純多血小板フィブリン(P-PRF)) - 世界の業界分析、規模、シェア、成長、動向、予測(2017〜2024年)

Platelet Rich Plasma (PRP) Market (Pure-Platelet Rich Plasma (P-PRP), Leukocyte-Platelet Rich Plasma (L-PRP), and Pure-Platelet-Rich Fibrin (P-PRF)) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2024

発行 Transparency Market Research 商品コード 641008
出版日 ページ情報 英文 176 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.47円で換算しております。
Back to Top
世界の多血小板血漿(PRP)市場(純多血小板血漿(P-PRP)、白血球・多血小板血漿(L-PRP)、純多血小板フィブリン(P-PRF)) - 世界の業界分析、規模、シェア、成長、動向、予測(2017〜2024年) Platelet Rich Plasma (PRP) Market (Pure-Platelet Rich Plasma (P-PRP), Leukocyte-Platelet Rich Plasma (L-PRP), and Pure-Platelet-Rich Fibrin (P-PRF)) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2024
出版日: 2018年04月26日 ページ情報: 英文 176 Pages
概要

当レポートでは、世界の多血小板血漿(PRP)市場について調査し、市場の現状と成長予測、タイプ別、源別、用途別、地域別動向、および市場に参入する企業のプロファイルなどをまとめています。

第1章 序論

第2章 仮定と調査方法

第3章 エグゼクティブサマリー

第4章 市場概要

  • イントロダクション
  • 製品概要
  • 業界動向
  • 市場指標

第5章 市場動向

  • 促進因子と阻害因子の概要分析
  • 促進因子
  • 阻害因子
  • 機会
  • バリューチェーン分析
  • 市場見通し

第6章 タイプ別市場分析

  • 主な調査結果
  • イントロダクション
  • 市場価値シェア分析
  • 市場予測
  • 市場分析
  • 市場の魅力度
  • 主な動向

第7章 源別市場分析

  • 主な調査結果
  • イントロダクション
  • 市場価値シェア分析
  • 市場予測
  • 市場分析
  • 市場の魅力度
  • 主な動向

第8章 用途別市場分析

  • 主な調査結果
  • イントロダクション
  • 市場価値シェア分析
  • 市場予測
  • 市場分析
  • 市場の魅力度

第9章 地域別市場分析

  • 市場概要
  • 市場価値シェア分析
  • 市場予測
  • 市場の魅力度

第10章 北米市場

第11章 欧州市場

第12章 アジア太平洋地域市場

第13章 ラテンアメリカ市場

第14章 中東・アフリカ市場

第15章 企業プロファイル

  • 市場シェア分析
  • 競合マトリクス
  • 企業プロファイル
    • Harvest Technologies Corporation
    • Arthrex, Inc.
    • Zimmer Biomet
    • DePuy Synthes, Inc.
    • Stryker Corporation
    • AdiStem Ltd.
    • ISTO Biologics
    • Cesca Therapeutics, Inc.
    • Emcyte Corporation
    • Nuo Therapeutics
    • Exactech Inc.
    • Regen Lab SA
図表

List of Tables

  • Table 01: Global Platelet-Rich Plasma Market Size (US$ Mn) Forecast, by Type, 2014-2024
  • Table 02: Global Platelet-Rich Plasma Market Size (US$ Mn) Forecast, by Origin, 2014-2024
  • Table 03: Global Platelet-Rich Plasma Market Size (US$ Mn) Forecast, by Application, 2014-2024
  • Table 04: Global Platelet-Rich Plasma Market Size (US$ Mn) Forecast, by Region, 2014-2024
  • Table 05: North America Platelet-Rich Plasma Market Size (US$ Mn) Forecast, by Country, 2014-2024
  • Table 06: North America Platelet-Rich Plasma Market Size (US$ Mn) Forecast, by Types, 2014-2024
  • Table 07: North America Platelet-Rich Plasma Market Size (US$ Mn) Forecast, by Origin, 2014-2024
  • Table 08: North America Platelet-Rich Plasma Market Size (US$ Mn) Forecast, by Applications, 2014-2024
  • Table 09: Europe Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Country/Region, 2014-2024
  • Table 10: Europe Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Type, 2014-2024
  • Table 11: Europe Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Origin, 2014-2024
  • Table 12: Europe Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Application, 2014-2024
  • Table 13: Asia Pacific Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Country/ Region, 2014-2024
  • Table 14: Asia Pacific Platelet-Rich Plasma Market Size (US$ Mn) Forecast, by Type, 2014-2024
  • Table 15: Asia Pacific Platelet-Rich Plasma Market Size (US$ Mn) Forecast, by Origin, 2014-2024
  • Table 16: Asia Pacific Platelet-Rich Plasma Market Size (US$ Mn) Forecast, by Application, 2014-2024
  • Table 17: Latin America Platelet-Rich Plasma Market Size (US$ Mn) Forecast, by Country, 2014-2024
  • Table 18: Latin America Platelet-Rich Plasma Market Size (US$ Mn) Forecast, by Type, 2014-2024
  • Table 19: Latin America Platelet-Rich Plasma Market Size (US$ Mn) Forecast, by Origin, 2014-2024
  • Table 20: Latin America Platelet-Rich Plasma Market Size (US$ Mn) Forecast, by Application, 2014-2024
  • Table 21: MEA Platelet-Rich Plasma Market Size (US$ Mn) Forecast, by Country/ Region, 2014-2024
  • Table 22: MEA Platelet-Rich Plasma Market Size (US$ Mn) Forecast, by Types, 2014-2024
  • Table 23: MEA Platelet-Rich Plasma Market Size (US$ Mn) Forecast, by Origin, 2014-2024
  • Table 24: MEA Platelet-Rich Plasma Market Size (US$ Mn) Forecast, by Applications, 2014-2024

List of Figures

  • Figure 01: Global Platelet-Rich Plasma Market Size (US$ Mn) Forecast, 2014-2024
  • Figure 02: Global Platelet-Rich Plasma Market Value Share Analysis, by Type, 2016 and 2024
  • Figure 03: Global Pure Platelet-Rich Plasma Market Revenue (US$ Mn), 2014-2024
  • Figure 04: Global Leukocyte-Rich Platelet-Rich Plasma Market Revenue (US$ Mn), 2014-2024
  • Figure 05: Global Pure Platelet-Rich Fibrin Market Revenue (US$ Mn), 2014-2024
  • Figure 06: Platelet-Rich Plasma Market Attractiveness Analysis, by Type, 2016-2024
  • Figure 07: Global Platelet-Rich Plasma Market Value Share Analysis, by Origin, 2016 and 2024
  • Figure 08: Global Autologous Platelet-Rich Plasma Market Revenue (US$ Mn), 2014-2024
  • Figure 09: Global Allogeneic Platelet-Rich Plasma Market Revenue (US$ Mn), 2014-2024
  • Figure 10: Global Homologous Platelet-Rich Plasma Market Revenue (US$ Mn), 2014-2024
  • Figure 11: Platelet-Rich Plasma Market Attractiveness Analysis, by Origin, 2016-2024
  • Figure 12: Global Platelet-Rich Plasma Market Value Share Analysis, by Application, 2016 and 2024
  • Figure 13: Global Orthopedic Surgery Market Revenue (US$ Mn), 2014-2024
  • Figure 14: Global Cosmetic Surgery Market Revenue (US$ Mn), 2014-2024
  • Figure 15: Global General Surgery Market Revenue (US$ Mn), 2014-2024
  • Figure 16: Global Neurosurgery Market Revenue (US$ Mn), 2014-2024
  • Figure 17: Global Other Surgeries Market Revenue (US$ Mn), 2014-2024
  • Figure 18: Platelet-Rich Plasma Market Attractiveness Analysis, by Application, 2016-2024
  • Figure 19: Global Platelet-Rich Plasma Market Value Share Analysis, by Region, 2016 and 2024
  • Figure 20: Platelet-Rich Plasma Market Attractiveness Analysis, by Region, 2016-2024
  • Figure 21: North America Platelet-Rich Plasma Market Size (US$ Mn) Forecast, 2014-2024
  • Figure 22: North America Market Attractiveness Analysis, by Country, 2016-2024
  • Figure 23: North America Market Value Share Analysis, by Country, 2016 and 2024
  • Figure 24: North America Market Value Share Analysis, by Types, 2016 and 2024
  • Figure 25: North America Market Value Share Analysis by Origin 2016 and 2024
  • Figure 26: North America Market Value Share Analysis, by Applications, 2016 and 2024
  • Figure 27: North America Market Attractiveness Analysis, by Types, 2016-2024
  • Figure 28: North America Market Attractiveness Analysis, by Origin, 2016-2024
  • Figure 29: North America Market Attractiveness Analysis, by Applications, 2016-2024
  • Figure 30: Europe Platelet-rich Plasma Market Size (US$ Mn) Forecast, 2014-2024
  • Figure 31: Europe Market Attractiveness Analysis, by Country/ Region, 2016-2024
  • Figure 32: Europe Market Value Share Analysis, by Country/Region, 2016 and 2024
  • Figure 33: Europe Market Value Share Analysis, by Type, 2016 and 2024
  • Figure 34: Europe Market Value Share Analysis, by Origin, 2016 and 2024
  • Figure 35: Europe Market Value Share Analysis, by Application, 2016 and 2024
  • Figure 36: Europe Market Attractiveness Analysis, by Type, 2016-2024
  • Figure 37: Europe Market Attractiveness Analysis, by Origin 2016-2024
  • Figure 38: Europe Market Attractiveness Analysis, by Application, 2016-2024
  • Figure 39: Asia Pacific Platelet-Rich Plasma Market Size (US$ Mn) Forecast, 2014-2024
  • Figure 40: Asia Pacific Market Attractiveness Analysis, by Country/Region, 2016-2024
  • Figure 41: Asia Pacific Market Value Share Analysis, by Country/ Region, 2016 and 2024
  • Figure 42: Asia Pacific Market Value Share Analysis, by Type, 2016 and 2024
  • Figure 43: Asia Pacific Market Value Share Analysis, by Origin, 2016 and 2024
  • Figure 44: Asia Pacific Market Value Share Analysis, by Application, 2016 and 2024
  • Figure 45: Asia Pacific Market Attractiveness Analysis, by Type, 2016-2024
  • Figure 46: Asia Pacific Market Attractiveness Analysis, by Origin, 2016-2024
  • Figure 47: Asia Pacific Market Attractiveness Analysis, by Application, 2016-2024
  • Figure 48: Latin America Platelet-Rich Plasma Market Size (US$ Mn) Forecast, 2014-2024
  • Figure 49: Latin America Market Attractiveness Analysis, by Country,
  • Figure 50: Latin America Market Value Share Analysis, by Country, 2016 and 2024
  • Figure 51: Latin America Market Value Share Analysis, by Type, 2016 and 2024
  • Figure 52: Latin America Market Value Share Analysis, by Origin, 2016 and 2024
  • Figure 53: Latin America Market Value Share Analysis, by Application, 2016 and 2024
  • Figure 54: Latin America Market Attractiveness Analysis, by Type, 2016-2024
  • Figure 55: Latin America Market Attractiveness Analysis, by Origin, 2016-2024
  • Figure 56: Latin America Market Attractiveness Analysis, by Application, 2016-2024
  • Figure 57: MEA Platelet-Rich Plasma Market Size (US$ Mn) Forecast, 2014-2024
  • Figure 58: MEA Market Attractiveness Analysis, by Country/ Region, 2016-2024
  • Figure 59: MEA Market Value Share Analysis, by Country, 2016 and 2024
  • Figure 60: MEA Market Value Share Analysis, by Types, 2016 and 2024
  • Figure 61: MEA Market Value Share Analysis, by Origin 2016 and 2024
  • Figure 62: MEA Market Value Share Analysis, by Applications, 2016 and 2024
  • Figure 63: MEA Market Attractiveness Analysis, by Types, 2016-2024
  • Figure 64: MEA Market Attractiveness Analysis, by Origin, 2016-2024
  • Figure 65: MEA Market Attractiveness Analysis, by Applications, 2016-2024
  • Figure 66: Global Platelet-Rich Plasma Market Share Analysis, by Company, (2015)
目次

Global Platelet Rich Plasma (PRP) Market: Overview

Platelet rich plasma (PRP) is a blood plasma product in which concentration of platelets is elevated four to eight times than normal blood platelet concentration. PRP is also called platelet rich gel, platelet enriched plasma and platelet enriched gel. PRP is an effective treatment to treat various diseases such as orthopedic diseases, sports injuries, neurological diseases and cardiothoracic diseases. In addition, PRP therapy has an extensive application in cosmetic industry. This report studies the current scenario as well as future market potential for PRP globally.

The market overview section of the report comprises qualitative analysis of the overall PRP market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter's five force analysis and market attractiveness analysis. In addition, such as market opportunity analysis, and key industry developments has also been provided. Key industry developments include the major events occurred in past decade and are expected to occur during the forecast period and are likely to affect the market dynamics.

Global Platelet Rich Plasma (PRP) Market: Segmentation

The global PRP market has been segmented on the basis of types, origins and applications. On the basis of types, the global PRP market is categorized as pure-PRP (P-PRP), leukocyte-rich PRP (L-PRP) and pure-platelet-rich fibrin (P-PRF). Moreover, on the basis of origin, the PRP market has been segmented into autologous, homologous and allogeneic PRP.

Furthermore, on the basis of applications, the global PRP market has been classified as neurosurgery, cosmetic surgery, orthopedic surgery, general surgery and others (cardiothoracic surgery, urology, periodontal surgery and oral and maxillofacial surgery). The market for these types, origins and applications has been extensively analyzed on the basis of factors such as usage pattern, sales revenue, geographic presence and technological developments. The market size and forecast in terms of revenue (USD million) for each of these segments have been provided for the period 2014 to 2024, considering 2016 as the base year. The report also provides the compounded annual growth rate (CAGR) for each segment for the forecast period 2017 to 2024.

Geographically, the PRP market has been classified into four segments namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The market size and forecast for each region has been provided for the period 2014 to 2024, in terms of origin, types and applications, along with the CAGR (%) for the forecast period 2017 to 2024.

Global Platelet Rich Plasma (PRP) Market: Competitive Landscape

The report also provides a section on the competitive landscape, wherein the market share analysis of leading players in the global PRP market, in terms of percentage share in 2015 has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and increase their market share.

It concludes with the profiles of major players in the global PRP market such as AdiStem Ltd., Arthrex, Inc., Biomet, Inc., Cesca Therapeutics, Inc., DePuy Synthes, Inc., EmCyte Corporation, Exactech, Inc., Harvest Technologies Corp., Nuo Therapeutics, Inc., Regen Lab SA, and Stryker Corporation. The major market players are evaluated on various parameters such as company overview, financial overview, product portfolio, business strategies and recent developments.

Table of Contents

Section 1: Preface

  • 1.1 Report Scope and Market Segmentation
  • 1.2 Research Highlights

Section 2: Assumptions and Research Methodology

  • 2.1 Assumptions
  • 2.2 Research Methodology

Section 3: Executive Summary

  • 3.1 Global Platelet Rich Plasma: Market Snapshot
  • 3.2 Global Market Share Analysis by Region, 2015
  • 3.3 Global Platelet-Rich Plasma Market: Opportunity Map

Section 4: Market Overview

  • 4.1 Product Overview
  • 4.2 Global Platelet-Rich Plasma Market: Key Industry Developments
  • 4.3 Global Platelet-Rich Plasma Market: Market Indicators

Section 5: Market Dynamics

  • 5.1 Drivers and Restraints Snapshot Analysis
  • 5.2 Drivers
    • 5.2.1 Increasing incidence of orthopedic and sports injuries
    • 5.2.2 Rising number of cosmetic surgical procedures
    • 5.2.3 Technological advancements and regulatory approvals for new devices
    • 5.2.4 Increasing popularity of PRP products and treatments
    • 5.2.5 Growing awareness about Platelet-Rich Plasma therapies
  • 5.3 Restraints
    • 5.3.1 Standardization in quality of allergen extracts
    • 5.3.2 Difficulty in quality control of test results
  • 5.4 Opportunities
    • 5.4.1 Ultrasound & Platelet Rich Plasma Therapy
    • 5.4.2 Advances in Technology & Devices will open new avenues
  • 5.5 Porters Analysis
  • 5.6 Value Chain Analysis
  • 5.7 Platelet-Rich Plasma Market Outlook

Section 6: Platelet-Rich Plasma Market Analysis, by Type

  • 6.1 Key Findings
  • 6.2 Introduction
  • 6.3 Global Platelet-Rich Plasma Market Value Share Analysis, by Type
  • 6.4 Platelet-Rich Plasma Market Forecast, by Type
  • 6.5 Platelet-Rich Plasma Market Analysis, by Type
    • 6.5.1 Pure-PRP
    • 6.5.2 Leukocyte-rich-PRP
    • 6.5.3 Pure-PRF
  • 6.6 Platelet-Rich Plasma Market Attractiveness Analysis, by Type
  • 6.7 Key Trends

Section 7: Platelet-Rich Plasma Market Analysis, by Origin

  • 7.1 Key Findings
  • 7.2 Introduction
  • 7.4 Platelet-Rich Plasma Market Forecast, by Origin
  • 7.5 Platelet-Rich Plasma Market Analysis, by Origin
    • 7.5.1 Autologous PRP
    • 7.5.2 Allogeneic PRP
    • 7.5.3 Homologous PRP
  • 7.6 Platelet-Rich Plasma Market Attractiveness Analysis, by Origin
  • 7.7 Key Trends

Section 8: Platelet-Rich Plasma Market Analysis, by Applications

  • 8.1 Key Findings
  • 8.2 Introduction
  • 8.3 Global Platelet-Rich Plasma Market Value Share Analysis, by Applications
  • 8.4 Platelet-Rich Plasma Market Forecast, by Applications
  • 8.5 Platelet-Rich Plasma Market Analysis, by Applications
    • 8.5.1 Orthopedic Surgery
    • 8.5.2 Cosmetic Surgery
    • 8.5.3 General Surgery
    • 8.5.4 Neurosurgery
    • 8.5.5 Others
  • 8.6 Platelet-Rich Plasma Market Attractiveness Analysis, by Applications

Section 9: Platelet-Rich Plasma Market Analysis, by Region

  • 9.1 Global Platelet-Rich Plasma Market Snapshot, by Country
  • 9.2 Global Platelet-Rich Plasma Market Value Share Analysis, by Region
  • 9.3 Platelet-Rich Plasma Market Forecast, by Region
  • 9.4 Market Attractiveness Analysis, by Region

Section 10: North America Platelet-Rich Plasma Market Analysis

  • 10.1 Key Findings
  • 10.2 Market Overview
  • 10.3 Market Analysis, by Country
    • 10.3.1 North America Market Value Share Analysis, by Country
    • 10.3.2 North America Market Forecast by Country
  • 10.4 Market Analysis, by Type
    • 10.4.1 North America Market Value Share Analysis, by Type
    • 10.4.2 North America Market Forecast, by Type
  • 10.5 Market Analysis, by Origin
    • 10.5.1 North America Market Value Share Analysis, by Origin
    • 10.5.2 North America Market Forecast, by Origin
  • 10.6 Market Analysis, by Applications
    • 10.6.1 North America Market Value Share Analysis, by Applications
    • 10.6.2 North America Market Forecast, by Applications
  • 10.7 North America Market Attractiveness Analysis
    • 10.7.1 By Type
    • 10.7.2 By Origin
    • 10.7.3 By Applications
  • 10.8 Market Trends

Section 11: Europe Platelet-Rich Plasma Market Analysis

  • 11.1 Key Findings
  • 11.2 Market Overview
  • 11.3 Market Analysis, by Country
    • 11.3.1 Europe Market Value Share Analysis, by Country
    • 11.3.2 Europe Market Forecast by Country
  • 11.4 Market Analysis, by Type
    • 11.4.1 Europe Market Value Share Analysis, by Type
    • 11.4.2 Europe Market Forecast, by Type
  • 11.5 Market Analysis, by Origin
    • 11.5.1 Europe Market Value Share Analysis, by Origin
    • 11.5.2 Europe Market Forecast, by Origin
  • 11.6 Market Analysis, by Applications
    • 11.6.1 Europe Market Value Share Analysis, by Applications
    • 11.6.2 Europe Market Forecast, by Applications
  • 11.7 Europe Market Attractiveness Analysis
    • 11.7.1 By Type
    • 11.7.2 By Origin
    • 11.7.3 By Applications
  • 11.8 Market Trends

Section 12: Asia Pacific Platelet-Rich Plasma Market Analysis

  • 12.1 Key Findings
  • 12.2 Market Overview
  • 12.3 Market Analysis, by Country
    • 12.3.1 Asia Pacific Market Value Share Analysis, by Country
    • 12.3.2 Asia Pacific Market Forecast by Country
  • 12.4 Market Analysis, by Type
    • 12.4.1 Asia Pacific Market Value Share Analysis, by Type
    • 12.4.2 Asia Pacific Market Forecast, by Type
  • 12.5 Market Analysis, by Origin
    • 12.5.1 Asia Pacific Market Value Share Analysis, by Origin
    • 12.5.2 Asia Pacific Market Forecast, by Origin
  • 12.6 Market Analysis, by Applications
    • 12.6.1 Asia Pacific Market Value Share Analysis, by Applications
    • 12.6.2 Asia Pacific Market Forecast, by Applications
  • 12.7 Asia Pacific Market Attractiveness Analysis
    • 12.7.1 By Type
    • 12.7.2 By Origin
    • 12.7.3 By Applications
  • 12.8 Market Trends

Section 13: Latin America Platelet-Rich Plasma Market Analysis

  • 13.1 Key Findings
  • 13.2 Market Overview
  • 13.3 Market Analysis, by Country
    • 13.3.1 Latin America Market Value Share Analysis, by Country
    • 13.3.2 Latin America Market Forecast by Country
  • 13.4 Market Analysis, by Type
    • 13.4.1 Latin America Market Value Share Analysis, by Type
    • 13.4.2 Latin America Market Forecast, by Type
  • 13.5 Market Analysis, by Origin
    • 13.5.1 Latin America Market Value Share Analysis, by Origin
    • 13.5.2 Latin America Market Forecast, by Origin
  • 13.6 Market Analysis, by Applications
    • 13.6.1 Latin America Market Value Share Analysis, by Applications
    • 13.6.2 Latin America Market Forecast, by Applications
  • 13.7 Latin America Market Attractiveness Analysis
    • 13.7.1 By Type
    • 13.7.2 By Origin
    • 13.7.3 By Applications
  • 13.8 Market Trends

Section 14: MEA Platelet-Rich Plasma Market Analysis

  • 14.1 Key Findings
  • 14.2 Market Overview
  • 14.3 Market Analysis, by Country
    • 14.3.1 MEA Market Value Share Analysis, by Country
    • 14.3.2 MEA Market Forecast by Country
  • 14.4 Market Analysis, by Type
    • 14.4.1 MEA Market Value Share Analysis, by Type
    • 14.4.2 MEA Market Forecast, by Type
  • 14.5 Market Analysis, by Origin
    • 14.5.1 MEA Market Value Share Analysis, by Origin
    • 14.5.2 MEA Market Forecast, by Origin
  • 14.6 Market Analysis, by Applications
    • 14.6.1 MEA Market Value Share Analysis, by Applications
    • 14.6.2 MEA Market Forecast, by Applications
  • 14.7 MEA Market Attractiveness Analysis
    • 14.7.1 By Type
    • 14.7.2 By Origin
    • 14.7.3 By Applications
  • 14.8 Market Trends

Section 15: Company Profiles

  • 15.1 Global Platelet-Rich Plasma Market Share Analysis, by Company (2015)
  • 15.2 Competition Matrix
  • 15.3 Company Profiles
    • 15.3.1 Harvest Technologies Corporation
      • 15.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
      • 15.3.1.2 Financial Overview
      • 15.3.1.3 Product Portfolio
      • 15.3.1.4 SWOT Analysis
      • 15.3.1.5 Strategic Overview
    • 15.3.2 Arthrex, Inc.
      • 15.3.2.1 Company Overview (HQ, Business Segments, Employee Strengths)
      • 15.3.2.2 Financial Overview
      • 15.3.2.3 Product Portfolio
      • 15.3.2.4 SWOT Analysis
      • 15.3.2.5 Strategic Overview
    • 15.3.3 Zimmer Biomet
      • 15.3.3.1 Company Overview (HQ, Business Segments, Employee Strengths)
      • 15.3.3.2 Financial Overview
      • 15.3.3.3 Product Portfolio
      • 15.3.3.4 SWOT Analysis
      • 15.3.3.5 Strategic Overview
    • 15.3.4 DePuy Synthes, Inc.
      • 15.3.4.1 Company Overview (HQ, Business Segments, Employee Strengths)
      • 15.3.4.2 Financial Overview
      • 15.3.4.3 Product Portfolio
      • 15.3.4.4 SWOT Analysis
      • 15.3.4.5 Strategic Overview
    • 15.3.5 Stryker Corporation
      • 15.3.5.1 Company Overview (HQ, Business Segments, Employee Strengths)
      • 15.3.5.2 Financial Overview
      • 15.3.5.3 Product Portfolio
      • 15.3.5.4 SWOT Analysis
      • 15.3.5.5 Strategic Overview
    • 15.3.6 AdiStem Ltd.
      • 15.3.6.1 Company Overview (HQ, Business Segments, Employee Strengths)
      • 15.3.6.2 Financial Overview
      • 15.3.6.3 Product Portfolio
      • 15.3.6.4 SWOT Analysis
      • 15.3.6.5 Strategic Overview
    • 15.3.7 ISTO Biologics
      • 15.3.7.1 Company Overview (HQ, Business Segments, Employee Strengths)
      • 15.3.7.2 Financial Overview
      • 15.3.7.3 Product Portfolio
      • 15.3.7.4 SWOT Analysis
      • 15.3.7.5 Strategic Overview
    • 15.3.8 Cesca Therapeutics, Inc.
      • 15.3.8.1 Company Overview (HQ, Business Segments, Employee Strengths)
      • 15.3.8.2 Financial Overview
      • 15.3.8.3 Product Portfolio
      • 15.3.8.4 SWOT Analysis
      • 15.3.8.5 Strategic Overview
    • 15.3.9 Emcyte Corporation
      • 15.3.9.1 Company Overview (HQ, Business Segments, Employee Strengths)
      • 15.3.9.2 Financial Overview
      • 15.3.9.3 Product Portfolio
      • 15.3.9.4 SWOT Analysis
      • 15.3.9.5 Strategic Overview
    • 15.3.10 Nuo Therapeutics
      • 15.3.10.1 Company Overview (HQ, Business Segments, Employee Strengths)
      • 15.3.10.2 Financial Overview
      • 15.3.10.3 Product Portfolio
      • 15.3.10.4 SWOT Analysis
      • 15.3.10.5 Strategic Overview
    • 15.3.11 Exactech Inc.
      • 15.3.11.1 Company Overview (HQ, Business Segments, Employee Strengths)
      • 15.3.11.2 Financial Overview
      • 15.3.11.3 Product Portfolio
      • 15.3.11.4 SWOT Analysis
      • 15.3.11.5 Strategic Overview
    • 15.3.12 Regen Lab SA
      • 15.3.12.1 Company Overview (HQ, Business Segments, Employee Strengths)
      • 15.3.12.2 Financial Overview
      • 15.3.12.3 Product Portfolio
      • 15.3.12.4 SWOT Analysis
      • 15.3.12.5 Strategic Overview
Back to Top